Cargando…
Cryopreservation Maintains Functionality of Human iPSC Dopamine Neurons and Rescues Parkinsonian Phenotypes In Vivo
A major challenge for clinical application of pluripotent stem cell therapy for Parkinson's disease (PD) is large-scale manufacturing and cryopreservation of neurons that can be efficiently prepared with minimal manipulation. To address this obstacle, midbrain dopamine neurons were derived from...
Autores principales: | Wakeman, Dustin R., Hiller, Benjamin M., Marmion, David J., McMahon, Christopher W., Corbett, Grant T., Mangan, Kile P., Ma, Junyi, Little, Lauren E., Xie, Zhong, Perez-Rosello, Tamara, Guzman, Jaime N., Surmeier, D. James, Kordower, Jeffrey H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5511045/ https://www.ncbi.nlm.nih.gov/pubmed/28579395 http://dx.doi.org/10.1016/j.stemcr.2017.04.033 |
Ejemplares similares
-
Optimizing maturity and dose of iPSC-derived dopamine progenitor cell therapy for Parkinson’s disease
por: Hiller, Benjamin M., et al.
Publicado: (2022) -
Mitomycin‐C treatment during differentiation of induced pluripotent stem cell‐derived dopamine neurons reduces proliferation without compromising survival or function in vivo
por: Hiller, Benjamin M., et al.
Publicado: (2020) -
Organ-Chips Enhance the Maturation of Human iPSC-Derived Dopamine Neurons
por: Otero, Maria G., et al.
Publicado: (2023) -
Rapid and Efficient Generation of Transgene-Free iPSC from a Small Volume of Cryopreserved Blood
por: Zhou, Hongyan, et al.
Publicado: (2015) -
Tideglusib Rescues Neurite Pathology of SPG11 iPSC Derived Cortical Neurons
por: Pozner, Tatyana, et al.
Publicado: (2018)